Aim An imbalance between antioxidant and pro-oxidant factors, with a predominance of the
latter, characterises oxidative stress and is indicative of a loss of vascular function. The …

The increase in cardiovascular disease and metabolic syndrome incidence following the
onset of menopause has highlighted the role of estrogen as a cardiometabolic protective …

Estrogen deprivation aggravates cardiac injury after myocardial ischemia and reperfusion
(I/R) injury. Although either estrogen or the dipeptidyl peptidase-4 (DPP-4) inhibitor …

One of the most prominent characteristics of hepatic ischemia-reperfusion injury (HI/R) is an
intense inflammatory reaction, which plays a key role in inflammatory injury induced by …

In this study, we investigated the effects of G-protein coupled estrogen receptor (GPER)
activation in the early phase of retinopathy of prematurity (ROP) and its association with …

Ventricular hypertrophy is a risk factors for arrhythmias, ischemia and sudden death. It
involves cellular modifications leading to a pathological remodeling and is associated with …

Epidemiological studies demonstrate disparities between men and women in cardiovascular
disease prevalence, clinical symptoms, treatments, and outcomes. Enrollment of women in …

The role of the adipocyte-derived factor visfatin in metabolism remains controversial,
although some pancreatic β-cell-specific effects have been reported. This study investigated …

The Importance of G-protein Coupled Estrogen Receptor in Patients With Fibromyalgia - PMC
Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI …

Nephrotoxicity is the dose-limiting side-effect of the chemotherapeutic agent cisplatin (Cp).
Recent evidence points to renal protective actions of G protein-coupled estrogen receptor 1 …